Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001628280-26-041263

Director acquired 35,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stoppel Laura Director 2026-06-03 Grant or award +35,500 48,300 D
Derivatives
Stoppel Laura Director 2026-06-03 Grant or award · Stock Option (right to buy) +53,250 53,250 D
Loading xslF345X06/wk-form4_1780691244.xml…